428 related articles for article (PubMed ID: 16572449)
1. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
3. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
4. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
5. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
6. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
7. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
8. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
9. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
10. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
11. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
14. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
[TBL] [Abstract][Full Text] [Related]
15. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
17. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
[TBL] [Abstract][Full Text] [Related]
18. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
Trouw LA; Haisma EM; Levarht EW; van der Woude D; Ioan-Facsinay A; Daha MR; Huizinga TW; Toes RE
Arthritis Rheum; 2009 Jul; 60(7):1923-31. PubMed ID: 19565507
[TBL] [Abstract][Full Text] [Related]
20. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
